| UniProt ID | PLCB2_HUMAN | |
|---|---|---|
| UniProt AC | Q00722 | |
| Protein Name | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 | |
| Gene Name | PLCB2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1185 | |
| Subcellular Localization | ||
| Protein Description | The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes.. | |
| Protein Sequence | MSLLNPVLLPPKVKAYLSQGERFIKWDDETTVASPVILRVDPKGYYLYWTYQSKEMEFLDITSIRDTRFGKFAKMPKSQKLRDVFNMDFPDNSFLLKTLTVVSGPDMVDLTFHNFVSYKENVGKAWAEDVLALVKHPLTANASRSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLCGPENSVLAQDKLLLHHDMTQPLNHYFINSSHNTYLTAGQFSGLSSAEMYRQVLLSGCRCVELDCWKGKPPDEEPIITHGFTMTTDIFFKEAIEAIAESAFKTSPYPIILSFENHVDSPRQQAKMAEYCRTIFGDMLLTEPLEKFPLKPGVPLPSPEDLRGKILIKNKKNQFSGPTSSSKDTGGEAEGSSPPSAPAGEGTVWAGEEGTELEEEEVEEEEEEESGNLDEEEIKKMQSDEGTAGLEVTAYEEMSSLVNYIQPTKFVSFEFSAQKNRSYVISSFTELKAYDLLSKASVQFVDYNKRQMSRIYPKGTRMDSSNYMPQMFWNAGCQMVALNFQTMDLPMQQNMAVFEFNGQSGYLLKHEFMRRPDKQFNPFSVDRIDVVVATTLSITVISGQFLSERSVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPELASLRVAVMEEGNKFLGHRIIPINALNSGYHHLCLHSESNMPLTMPALFIFLEMKDYIPGAWADLTVALANPIKFFSAHDTKSVKLKEAMGGLPEKPFPLASPVASQVNGALAPTSNGSPAARAGAREEAMKEAAEPRTASLEELRELKGVVKLQRRHEKELRELERRGARRWEELLQRGAAQLAELGPPGVGGVGACKLGPGKGSRKKRSLPREESAGAAPGEGPEGVDGRVRELKDRLELELLRQGEEQYECVLKRKEQHVAEQISKMMELAREKQAAELKALKETSENDTKEMKKKLETKRLERIQGMTKVTTDKMAQERLKREINNSHIQEVVQVIKQMTENLERHQEKLEEKQAACLEQIREMEKQFQKEALAEYEARMKGLEAEVKESVRACLRTCFPSEAKDKPERACECPPELCEQDPLIAKADAQESRL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSLLNPVLL ------CCCCCCCCC | 53.52 | - | |
| 48 | Phosphorylation | DPKGYYLYWTYQSKE CCCCEEEEEEEECCC | 4.60 | 30576142 | |
| 51 | Phosphorylation | GYYLYWTYQSKEMEF CEEEEEEEECCCEEE | 9.17 | 30576142 | |
| 56 | Sulfoxidation | WTYQSKEMEFLDITS EEEECCCEEEEECCE | 5.19 | 21406390 | |
| 62 | Phosphorylation | EMEFLDITSIRDTRF CEEEEECCEECCCCC | 20.12 | 18452278 | |
| 63 | Phosphorylation | MEFLDITSIRDTRFG EEEEECCEECCCCCH | 18.89 | 30576142 | |
| 208 | Phosphorylation | EDFPEPVYKSFLMSL HHCCHHHHHHHHHHH | 16.19 | - | |
| 210 | Phosphorylation | FPEPVYKSFLMSLCP CCHHHHHHHHHHHCC | 13.11 | 25404012 | |
| 214 | Phosphorylation | VYKSFLMSLCPRPEI HHHHHHHHHCCCHHH | 29.03 | 22210691 | |
| 235 | Phosphorylation | YHAKAKPYMTKEHLT HHHCCCCCCCHHHHH | 19.40 | 26657352 | |
| 237 | Phosphorylation | AKAKPYMTKEHLTKF HCCCCCCCHHHHHHH | 27.69 | 29083192 | |
| 274 | Phosphorylation | VQGLIDKYEPSGINA HCHHHHHCCCCCCCC | 29.35 | - | |
| 277 | Phosphorylation | LIDKYEPSGINAQRG HHHHCCCCCCCCCCC | 40.12 | - | |
| 332 | Phosphorylation | SSHNTYLTAGQFSGL CCCCCEEECCCCCCC | 20.51 | - | |
| 337 | Phosphorylation | YLTAGQFSGLSSAEM EEECCCCCCCCHHHH | 30.82 | - | |
| 351 | Phosphorylation | MYRQVLLSGCRCVEL HHHHHHHHCCEEEEE | 31.52 | 29083192 | |
| 394 | Phosphorylation | AIEAIAESAFKTSPY HHHHHHHHHHCCCCC | 29.95 | 28270605 | |
| 406 | Phosphorylation | SPYPIILSFENHVDS CCCCEEEEEECCCCC | 21.80 | 27251275 | |
| 413 | Phosphorylation | SFENHVDSPRQQAKM EEECCCCCHHHHHHH | 22.39 | 27251275 | |
| 419 | Ubiquitination | DSPRQQAKMAEYCRT CCHHHHHHHHHHHHH | 34.01 | - | |
| 419 | Ubiquitination | DSPRQQAKMAEYCRT CCHHHHHHHHHHHHH | 34.01 | - | |
| 450 | Phosphorylation | KPGVPLPSPEDLRGK CCCCCCCCHHHHCCC | 48.91 | - | |
| 474 | Phosphorylation | FSGPTSSSKDTGGEA CCCCCCCCCCCCCCC | 34.03 | - | |
| 531 | Phosphorylation | EEIKKMQSDEGTAGL HHHHHHHCCCCCCCC | 33.84 | 22210691 | |
| 535 | Phosphorylation | KMQSDEGTAGLEVTA HHHCCCCCCCCEEEE | 18.59 | 22210691 | |
| 547 | Phosphorylation | VTAYEEMSSLVNYIQ EEEHHHHHHHHHHHC | 24.65 | 22210691 | |
| 552 | Phosphorylation | EMSSLVNYIQPTKFV HHHHHHHHHCCCCEE | 8.08 | 25884760 | |
| 556 | Phosphorylation | LVNYIQPTKFVSFEF HHHHHCCCCEEEEEE | 22.27 | 22210691 | |
| 560 | Phosphorylation | IQPTKFVSFEFSAQK HCCCCEEEEEEECCC | 23.38 | 22210691 | |
| 570 | Phosphorylation | FSAQKNRSYVISSFT EECCCCCCEEEEECC | 32.90 | 22817900 | |
| 571 | Phosphorylation | SAQKNRSYVISSFTE ECCCCCCEEEEECCH | 9.88 | 18187866 | |
| 574 | Phosphorylation | KNRSYVISSFTELKA CCCCEEEEECCHHHH | 14.89 | 18187866 | |
| 575 | Phosphorylation | NRSYVISSFTELKAY CCCEEEEECCHHHHH | 25.68 | 18187866 | |
| 577 | Phosphorylation | SYVISSFTELKAYDL CEEEEECCHHHHHHH | 42.21 | 28111955 | |
| 597 | Phosphorylation | VQFVDYNKRQMSRIY EEEECCCCCHHHCCC | 37.47 | 17081983 | |
| 600 | Phosphorylation | VDYNKRQMSRIYPKG ECCCCCHHHCCCCCC | 3.18 | 17081983 | |
| 601 | Phosphorylation | DYNKRQMSRIYPKGT CCCCCHHHCCCCCCC | 13.74 | 25599653 | |
| 604 | Phosphorylation | KRQMSRIYPKGTRMD CCHHHCCCCCCCCCC | 9.59 | 17081983 | |
| 672 | Phosphorylation | DKQFNPFSVDRIDVV CCCCCCCCCCCCCEE | 25.10 | - | |
| 698 | Phosphorylation | GQFLSERSVRTYVEV CCCCCCCCEEEEEEE | 16.35 | 21712546 | |
| 701 | Phosphorylation | LSERSVRTYVEVELF CCCCCEEEEEEEEEE | 29.75 | 21712546 | |
| 718 | Phosphorylation | PGDPKRRYRTKLSPS CCCHHHHHCCCCCCC | 27.02 | - | |
| 728 | Phosphorylation | KLSPSTNSINPVWKE CCCCCCCCCCCCCCC | 24.67 | 19413330 | |
| 750 | Phosphorylation | ILMPELASLRVAVME HHCHHHHHHEEEEEC | 29.36 | 24719451 | |
| 757 (in isoform 2) | Ubiquitination | - | 57.04 | 21890473 | |
| 761 | Ubiquitination | AVMEEGNKFLGHRII EEECCCCEECCCCEE | 53.47 | 21890473 | |
| 761 | Ubiquitination | AVMEEGNKFLGHRII EEECCCCEECCCCEE | 53.47 | 21890473 | |
| 761 (in isoform 1) | Ubiquitination | - | 53.47 | 21890473 | |
| 874 | Methylation | PAARAGAREEAMKEA HHHHHCHHHHHHHHH | 41.17 | 24384387 | |
| 886 | Phosphorylation | KEAAEPRTASLEELR HHHCCCCCCCHHHHH | 31.17 | 28060719 | |
| 888 | Phosphorylation | AAEPRTASLEELREL HCCCCCCCHHHHHHH | 35.38 | 23401153 | |
| 893 | Methylation | TASLEELRELKGVVK CCCHHHHHHHHHHHH | 50.94 | 24384397 | |
| 953 | Phosphorylation | KLGPGKGSRKKRSLP CCCCCCCCCCCCCCC | 44.40 | 14702039 | |
| 958 | Phosphorylation | KGSRKKRSLPREESA CCCCCCCCCCHHHHC | 52.16 | 24670416 | |
| 964 | Phosphorylation | RSLPREESAGAAPGE CCCCHHHHCCCCCCC | 27.52 | 23401153 | |
| 1015 | Phosphorylation | QHVAEQISKMMELAR HHHHHHHHHHHHHHH | 17.75 | 30108239 | |
| 1035 | Phosphorylation | ELKALKETSENDTKE HHHHHHHCCCCHHHH | 39.49 | - | |
| 1036 | Phosphorylation | LKALKETSENDTKEM HHHHHHCCCCHHHHH | 35.18 | - | |
| 1040 | Phosphorylation | KETSENDTKEMKKKL HHCCCCHHHHHHHHH | 40.25 | - | |
| 1117 | Ubiquitination | EQIREMEKQFQKEAL HHHHHHHHHHHHHHH | 55.92 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PLCB2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLCB2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLCB2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRPM7_HUMAN | TRPM7 | physical | 11941371 | |
| PLCB2_HUMAN | PLCB2 | physical | 11753430 | |
| MP2K3_HUMAN | MAP2K3 | physical | 12054652 | |
| MP2K6_HUMAN | MAP2K6 | physical | 12054652 | |
| MK14_HUMAN | MAPK14 | physical | 12054652 | |
| WDR36_HUMAN | WDR36 | physical | 21940795 | |
| TA2R_HUMAN | TBXA2R | physical | 21940795 | |
| GNAQ_HUMAN | GNAQ | physical | 21940795 | |
| NHRF2_HUMAN | SLC9A3R2 | physical | 10748023 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...